[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335630-105":59,"doc-detail-335630-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biological-markers-of-myeloproliferative-neoplasms-in-children-adolescents-and-young-adults-review-and-genetic-diagnostics","Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults - review and genetic diagnostics","","Myeloproliferative neoplasms (MPNs) are clonal hematopoietic cancers marked by hyperproliferation of myeloid lineages and are extremely rare in pediatric patients. The review summarizes how modern, primarily genetic, diagnostics reveal disease biology and guide clinical decision-making. It highlights driver mutations in JAK2, MPL, and CALR (about 90% of suspected cases) and details more than 20 additional mutations affecting pathogenesis. The paper also describes disruptions in JAK/STAT signaling, DNA methylation, chromatin structure, and splicing pathways. It aims to improve knowledge and identify genetic targets for diagnosis and therapy in children, adolescents, and young adults.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biological-markers-of-myeloproliferative-neoplasms-in-children-adolescents-and-young-adults-review-and-genetic-diagnostics/335630/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biological-markers-of-myeloproliferative-neoplasms-in-children-adolescents-and-young-adults-review-and-genetic-diagnostics/335630.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are pediatric myeloproliferative neoplasms difficult to study compared with adults?","Question",{"text":112,"@type":113},"MPNs occur much less frequently in children and adolescents than in adults, so pediatric cohorts are small. This has historically limited data and research focus.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which mutations are considered key driver genes in MPNs?",{"text":117,"@type":113},"JAK2, MPL, and CALR are identified as driver mutations. They are present in approximately 90% of patients with suspected MPN.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological pathways are implicated in MPN pathogenesis?",{"text":121,"@type":113},"The review describes dysregulation of JAK/STAT signaling, alterations in DNA methylation, changes in chromatin structure, and defects in mRNA splicing. Examples include TET2, DNMT3A, ASXL1, EZH2, SF3B1, and U2AF2.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335630,1790194289,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Review  \nBiological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults  \nAleksandra Ozygała 1, Joanna Rokosz-Mierzwa 2, Paulina Widz 3, Paulina Skowera 1, Mateusz Wili ´nski 2, Borys Styka 1 and Monika Lejman 1, *  \nCitation: Ozygała, A.;  \nRokosz-Mierzwa, J.; Widz, P.; Skowera, P.; Wili ´nski, M.; Styka, B.; Lejman, M. Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults. Cancers 2024, 16, 4114 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16234114  \nAcademic Editor: Eishi Ashihara  \nReceived: 12 November 2024  \nRevised: 28 November 2024  \nAccepted: 5 December 2024  \nPublished: 8 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland;  \n[aleksandra.ozygala@uszd.lublin.pl](aleksandra.ozygala@uszd.lublin.pl) (A.O.); [paulina.skowera@umlub.pl](paulina.skowera@umlub.pl) (P.S.); [borys.styka@umlub.pl](borys.styka@umlub.pl) (B.S.)  \n2 Department of Genetic Diagnostics, University Children’s Hospital, 20-093 Lublin, Poland; [joanna.rokosz-mierzwa@uszd.lublin.pl](joanna.rokosz-mierzwa@uszd.lublin.pl) (J.R.-M.); [mateusz.wilinski@uszd.lublin.pl](mateusz.wilinski@uszd.lublin.pl) (M.W.)  \n3 Student Scientific Society of Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-059 Lublin, Poland; [paulina.widz@wp.pl](paulina.widz@wp.pl)  \n* [Correspondence: monika.lejman@umlub.pl](Correspondence: monika.lejman@umlub.pl)  \nSimple Summary: Myeloproliferative neoplasms (MPNs) are exceedingly rare in children, adolescents, and young adults. The current literature focuses mainly on older patients, so the purpose of thereview is to present the genetic landscape of pediatric patients. Modern genetic diagnostics makes it possible to identify genetic markers involved in the pathomechanisms of these uncommon clonal marrow disorders. Excluding driver gene mutations (JAK2, MPL, CALR), over 20 other mutations have been described as of significance to MPNs. The aim of the review is to improve and present knowledge of MPNs and genetic targets for diagnosis and therapy in children, adolescents, and young adults.  \nAbstract: Myeloproliferative neoplasms (MPNs) are clonal hematopoietic cancers characterized by hyperproliferation of the myeloid lineages. These clonal marrow disorders are extremely rare in pediatric patients. MPN is reported to occur 100 times more frequently in adults, and thus research is primarily focused on this patient group. At present, modern diagnostic techniques, primarily genetic, facilitate the identification of the biology of these diseases. The key genes are JAK2, MPL, and CALR, namely, driver mutations, which are present in approximately 90% of patients with suspected MPN. Moreover, there are more than 20 other mutations that affect the development of these hematological malignancies, as evidenced by a review of the literature. The pathogenic mechanism of MPNs is characterized by the dysregulation of the JAK/STAT signaling pathway (JAK2, MPL, CALR), DNA methylation (TET2, DNMT3A, IDH1/2), chromatin structure (ASXL1, EZH2), and splicing (SF3B1, U2AF2, SRSF2) . Although rare, myeloproliferative neoplasms can involve young patients and pose unique challenges for clinicians in diagnosis and therapy. The paper aims to review the biological markers of MPNs in pediatric populations—a particular group of patients that has been poorly studied due to the low frequency of MPN diagnosis.  \nKeywords: myeloproliferative neoplasm; children; chronic myeloid leukemia (CML); polycythemia vera (P","cbCaiusxcFEyAGh2","https://ap.wps.com/l/cbCaiusxcFEyAGh2","pdf",372759,22,"English","# Introduction\n# Classification of MPN","[{\"question\":\"Why are pediatric myeloproliferative neoplasms difficult to study compared with adults?\",\"answer\":\"MPNs occur much less frequently in children and adolescents than in adults, so pediatric cohorts are small. This has historically limited data and research focus.\"},{\"question\":\"Which mutations are considered key driver genes in MPNs?\",\"answer\":\"JAK2, MPL, and CALR are identified as driver mutations. They are present in approximately 90% of patients with suspected MPN.\"},{\"question\":\"What biological pathways are implicated in MPN pathogenesis?\",\"answer\":\"The review describes dysregulation of JAK/STAT signaling, alterations in DNA methylation, changes in chromatin structure, and defects in mRNA splicing. Examples include TET2, DNMT3A, ASXL1, EZH2, SF3B1, and U2AF2.\"}]","Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults - review and genetic diagnostics | PDF",1790011714,55]